About the CentriMag Acute Cirulatory Support System
Excellent hemocompatibility and unparalleled versatility for optimized patient care.
The CentriMag™ Acute Circulatory Support System is a blood pumping system used to support patients with acute heart and lung failure.
The CentriMag™ Device is the ONLY acute circulatory support system approved for 30-day VAD use* and cleared for ECMO** allowing escalation and de-escalation of therapy.1-3,*
Confidence in a snap with the new motor locking mechanism
The CentriMag motor has been updated with streamlined lock design for a simple locking process. Two spring-loaded levers automatically lock the CentriMag™ or PediMag™ blood pumps into the motor for effortless insertion. Multiple points of contact provide a strong hold to keep the pump in place, providing confidence in insertion stability.
Addressing the broadest spectrum of clinical challenges
The CentriMag blood pump functions as:
- Part of an ECMO†† circuit for periods > 6 hours
- Temporary circulatory support for periods up to 30 days* to support the left, right, or both ventricles of the heart in patients who fail to wean from cardiopulmonary bypass
Optimal Patient Care for a Variety of Applications
Designed for Optimal Hemocompatibility4,5
Driven by Full MagLev™ Flow Technology, the CentriMag and PediMag Pumps include a free-floating magnetically levitated rotor for a contact-free environment. This innovative technology results in excellent hemodynamics, which can lead to minimized blood stagnation, friction and shear stress.6,7
Reduced blood trauma,6 minimized turbulence, maintained stability
Full MagLev Flow Technology provides a contact-free environment that features:
- A free-floating magnetically levitated rotor to prevent surface-to-surface contact that could cause blood trauma
- Wide blood-flow pathways and absence of seals, bearings and valves to minimize blood turbulence and stasis
- Automatic rotor positioning that adjusts 50,000 times per second to maintain stable and consistent blood flow
Trusted for a wide range of patient types and size
Produces flows of up to 10 LPM with fewer rotations per minute
The CentriMag System includes both pediatric and adult pump options, producing flows up to 1.5 LPM for pediatric, and 10 LPM for adult.
CentriMag Pump
PediMag Pump
*PMA approval for 30-day use of CentriMag System components include: CentriMag™ Pump, CentriMag™ Console, CentriMag™ Motor, Mag Monitor, Flow Probe, and CentriMag™ Drainage Cannula and CentriMag™ Return Cannula. Optional accessories include: CentriMag™ System Cart, CentriMag™ System Transporter and Pressure Transducer. PMA approval for 30-day use of CentriMag™ System excludes: PediMag™ Blood Pump and any other pediatric components or accessories.
**ECMO clearance for >6-hour use is indicated for the CentriMag™ Blood Pump to be used with: CentriMag™ Console, CentriMag™ Motor, Mag Monitor, and Flow Probe. Optional accessories include: CentriMag™ System Cart, CentriMag™ System Transporter and Pressure Transducer. ECMO clearance for the CentriMag™ Blood Pump is for adult use only.
† Approved for 30-day use
†† COVID-19 Temporary Expanded Indication under US FDA enforcement policy guidance
References
- Takeda K, Garan AR, Ando M, et al. Minimally invasive CentriMag ventricular assist device support integrated with extracorporeal membrane oxygenation in cardiogenic shock patients: a comparison with conventional CentriMag biventricular support configuration. Eur J Cardio-Thorac Surg. 2017;52:1055-1061.
- Worku B, Pak S-W, van Patten D, et al. The CentriMag ventricular assist device in acute heart failure refractory to medical management. J Heart Lung Transplant. 2012;31:611-617.
- Takayama H, Soni L, Kalesan B, et al. Bridge-to-decision therapy with a continuous-flow external ventricular assist device in refractory cardiogenic shock of various causes. Circ Heart Fail. 2014;7:799-806.
- John, R., Liao, K., Lietz, K., Kamdar, F., Colvin-Adams, M., Boyle, A., … Joyce, Lyle. (2007). Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. The Journal of Thoracic and Cardiovascular Surgery, 134(2), 351-358. https://dx.doi.org/10.1016/j.jtcvs.2007.01.085
- John, R., Long, J. W., Massey, H. T., Griffith, B. P., Sun, B. C., Tector, A. J., … Joyce, L. D. (2011). Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. The Journal of Thoracic and Cardiovascular Surgery, 141(4), 932-939. https://dx.doi.org/10.1016/j.jtcvs.2010.03.046
- Aziz, T. A., Singh, G., Popjes, E., Stephenson, E., Mulvey, S., Pae, W., & El-Banayosy, A. (2010). Initial experience with CentriMag extracorporeal membrane oxygenation for support of critically ill patients with refractory cardiogenic shock. The Journal of Heart and Lung Transplantation, 29(1), 66-71. https://dx.doi.org/10.1016/j.healun.2009.08.025
- Bhama, J. K., Kornos, R. L., Toyoda, Y., Teuteberg, J. J., McCurry, K. R., & Siegenthaler, M. P. (2009). Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. The Journal of Heart and Lung Transformation, 28(9), 971-976. https://www.jhltonline.org/article/S1053-2498(09)00238-1/fulltext
MAT-2012990 v4.0